A detailed history of Cahaba Wealth Management, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Cahaba Wealth Management, Inc. holds 3,906 shares of ABT stock, worth $452,705. This represents 0.04% of its overall portfolio holdings.

Number of Shares
3,906
Previous 3,903 0.08%
Holding current value
$452,705
Previous $405,000 9.88%
% of portfolio
0.04%
Previous 0.04%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

BUY
$100.07 - $118.13 $300 - $354
3 Added 0.08%
3,906 $445,000
Q2 2024

Aug 05, 2024

SELL
$100.73 - $112.44 $7,554 - $8,433
-75 Reduced 1.89%
3,903 $405,000
Q1 2024

Apr 22, 2024

SELL
$109.52 - $120.96 $5,147 - $5,685
-47 Reduced 1.17%
3,978 $452,000
Q4 2023

Jan 23, 2024

SELL
$90.19 - $110.4 $17,587 - $21,528
-195 Reduced 4.62%
4,025 $443,000
Q3 2023

Oct 18, 2023

SELL
$95.53 - $114.62 $58,082 - $69,688
-608 Reduced 12.59%
4,220 $408,000
Q2 2023

Jul 26, 2023

SELL
$100.78 - $112.29 $23,380 - $26,051
-232 Reduced 4.58%
4,828 $526,000
Q1 2023

May 04, 2023

SELL
$96.86 - $114.01 $11,042 - $12,997
-114 Reduced 2.2%
5,060 $512,000
Q4 2022

Jan 30, 2023

BUY
$95.06 - $111.52 $30,229 - $35,463
318 Added 6.55%
5,174 $568,000
Q3 2022

Oct 18, 2022

SELL
$96.76 - $112.03 $13,643 - $15,796
-141 Reduced 2.82%
4,856 $469,000
Q2 2022

Jul 19, 2022

SELL
$102.07 - $123.37 $45,217 - $54,652
-443 Reduced 8.14%
4,997 $542,000
Q1 2022

May 05, 2022

BUY
$114.02 - $139.04 $60,544 - $73,830
531 Added 10.82%
5,440 $617,000
Q4 2021

Feb 01, 2022

BUY
$115.53 - $141.46 $63,194 - $77,378
547 Added 12.54%
4,909 $691,000
Q3 2021

Oct 15, 2021

BUY
$116.66 - $129.06 $508,870 - $562,959
4,362 New
4,362 $515,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $203B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Cahaba Wealth Management, Inc. Portfolio

Follow Cahaba Wealth Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cahaba Wealth Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cahaba Wealth Management, Inc. with notifications on news.